For: | Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study. World J Stem Cells 2024; 16(6): 641-655 [PMID: 38948099 DOI: 10.4252/wjsc.v16.i6.641] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v16/i6/641.htm |
Number | Citing Articles |
1 |
Ningcen Li, Wenhui Lu, Limei Tang, Lina Zhu, Weibin Deng, Hang Liu, Changquan Huang, Jingying Jin, Jingjiao Zeng, Shitai Chen, Lianqi Geng, Xiuwu Hu, Liang Zhou. Microglia in Post‐Traumatic Brain Injury (TBI) Cognitive Impairment: From Pathological Changes to Therapeutic Approaches. CNS Neuroscience & Therapeutics 2025; 31(8) doi: 10.1111/cns.70568
|
2 |
Muzamil Akhtar, Abdulqadir J Nashwan. Evaluating Wharton’s jelly-derived stem cell therapy in autism: Insights from a case study. World Journal of Methodology 2025; 15(2): 100074 doi: 10.5662/wjm.v15.i2.100074
|
3 |
Qian Zhou, Wei Shen, Liang Wen. Advances in clinical neurorestorative treatments in brain trauma. Journal of Neurorestoratology 2025; 13(3): 100191 doi: 10.1016/j.jnrt.2025.100191
|
4 |
P. R. Kamchatnov, O. Yu. Tsarapkina, N. G. Malyukova, A. V. Miretskaya, E. F. Danshina, L. A. Skipetrova, R. A. Cheremin. Treatment of post-traumatic cognitive disorders and asthenia: results of an observational study. Neurology, Neuropsychiatry, Psychosomatics 2024; 16(4): 14 doi: 10.14412/2074-2711-2024-4-14-20
|